Haining Huang Email

CSO, Cytimm Therapeutics . Sorrento Therapeutics

Current Roles

Employees:
247
Revenue:
$21.2M
About
Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.
Sorrento Therapeutics Address
4955 Directors Place
San Diego, CA
United States
Sorrento Therapeutics Email

Past Companies

Sorrento Therapeutics, Inc.CSO, Cytimm Therapeutics
ACEA TherapeuticsVP Drug Discovery
Oxford BioTherapeuticsSr. Director, Head of Immuno Oncology

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.